Two tests can agree without proving that either identifies the condition correctly. Accuracy claims depend on what was used to establish whether the condition was present.
FDA's primary diagnostic-test guidance distinguishes comparison with a reference standard from comparison with a non-reference method. Agreement with the latter is reported as positive and negative percent agreement rather than being automatically labelled sensitivity and specificity. The comparator, condition definition, sampling and uncertainty need to remain visible. Treating agreement as accuracy can conceal shared errors or an imperfect comparator.
Shares Analytical versus clinical validation, Evidence from measurement to patient benefit.
Shares Analytical versus clinical validation, Sensitivity and specificity, Evidence from measurement to patient benefit.
Shares Analytical versus clinical validation, Evidence from measurement to patient benefit.
Shares Analytical versus clinical validation, Evidence from measurement to patient benefit.
Shares Analytical versus clinical validation, Evidence from measurement to patient benefit.
Shares Sensitivity and specificity, Positive predictive value (PPV).
Shares Sensitivity and specificity, Positive predictive value (PPV).
Shares Sensitivity and specificity, Positive predictive value (PPV).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/